This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 6 of 16 for:    cancer | Studies received from 04/21/2016 to 04/21/2016

The Feasibility of an Active Lifestyle Programme in Patients Recovering From Colorectal Cancer (MOVE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of East Anglia
ClinicalTrials.gov Identifier:
NCT02751892
First received: April 21, 2016
Last updated: April 21, 2016
Last verified: April 2016
  Purpose
Long-term maintenance of physical activity behaviour change post-intervention remains challenging. This study is investigating the feasibility of a behaviour change intervention based on Self-Determination Theory in people recovering from colorectal cancer and its effects on behaviour change 6 months post-intervention.

Condition Intervention
Colorectal Cancer Behavioral: Active lifestyle programme

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Feasibility of a Physical Activity Intervention Informed by Self-Determination Theory With Patients Recovering From Colorectal Cancer

Resource links provided by NLM:


Further study details as provided by University of East Anglia:

Primary Outcome Measures:
  • Change in minutes spent in moderate and vigorous intensity physical activity measure with the International Physical Activity Questionnaire long version [ Time Frame: 0, 3, 6 months ]

Secondary Outcome Measures:
  • Change in behavioural regulation measure with the Behavioural Regulation in Exercise Questionnaire version 2 [ Time Frame: 0, 3, 6 months ]
  • Change in psychological needs satisfaction measured with the psychological needs satisfaction in exercise scale [ Time Frame: 0, 3, 6 months ]
  • Change in quality of life measure with the Functional Assessment of Cancer Therapy general [ Time Frame: 0, 3, 6 months ]
  • Change in quality of life measure with the Functional Assessment of Cancer Therapy-colorectal [ Time Frame: 0, 3, 6 months ]
  • Change in fatigue with the Functional Assessment of Cancer Therapy - fatigue [ Time Frame: 0, 3, 6 months ]
  • Change in intention to exercise [ Time Frame: 0, 3, 6 months ]
    assessed with Intention to exercise scale

  • Change in barriers to exercise [ Time Frame: 0, 3, 6 months ]
    assessed with Barriers to Exercise scale

  • Change in physical fitness [ Time Frame: 0, 3, and 6 months ]
    assessed with the modified Bruce treadmill test

  • Change in upper body strength-grip strength [ Time Frame: 0, 3, 6 months ]
    Assessed with grip dynanometer

  • Change in upper body strength-upper arm strength [ Time Frame: 0, 3, 6 months ]
    Assessed with biceps curl test

  • Change in lower body strength [ Time Frame: 0, 3, 6 months ]
    Assessed with 30 sec sit-to-stand test

  • Changes in body composition (% body fat) assessed with bioelectrical impedance analysis [ Time Frame: 0, 3, 6 months ]
  • Change in antropometric measures (waist circumference, hip circumference [ Time Frame: 0, 3, 6 months ]
    Waist and hip circumference will be used to calculate the waist-to-hip ratio

  • Changes in anthropometric measures (height, weight, BMI) [ Time Frame: 0, 3, 6 months ]
    Body weight and body height will be used to calculate BMI

  • Change in minutes spent in moderate and vigorous intensity physical activity with accelerometry [ Time Frame: 0, 3, 6 months ]

Enrollment: 28
Study Start Date: October 2013
Study Completion Date: September 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Active Lifestyle Programme
Supervised exercises for 3 months and motivational interviewing to facilitate physical activity behaviour change. Supervised exercise sessions took place twice per week for the first four weeks. This was tapered off to once per week for the second four weeks. During the last month of the intervention participants continued with the exercise at home and were encouraged to achieve 150min of moderate to vigorous PA per week.
Behavioral: Active lifestyle programme
The intervention is an activity lifestyle programme to increase physical activity behaviour post-intervention and to facilitate behaviour change maintenance at 3 months post-intervention.
Other Name: MOVE
No Intervention: Standard Care
Received usual care. Was offered the intervention after the completion of the study.

Detailed Description:

This study was a randomized controlled feasibility trial consisting of a 3-months active lifestyle intervention and a 3-months follow-up period. Participants were allocated to an active lifestyle programme (ALP) or the standard (SC) care group. ALP was offered 12 supervised exercise sessions over 3 months and six supportive behaviour change workshops. SC was encouraged to continue with their usual lifestyle. The intervention was informed by Self-Determination Theory.

The supervised exercise sessions took place in small groups of maximum 7 participants and lasted approximately 1 hour. Exercise included aerobic and resistance exercises. The behaviour change workshops were delivered in a motivational interviewing style, also in small groups of maximum 7 participants.

Participants were followed-up at 6 months. There was no contact with participants during the post-intervention and follow-up period.

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • a histologically confirmed diagnosis of colorectal cancer with Dukes stages A-C
  • completed cancer treatment within the last 24 months,
  • be able to understand spoken and written English
  • score of 80 or more on the Karnofsky Performance Status Scale

Exclusion Criteria:

  • already meeting general PA guidelines of 150 min of moderate PA or 75 min of vigorous intensity PA per week,
  • recent myocardial infarction
  • uncontrolled hypertension
  • a pacemaker
  • or unstable angina.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02751892

Sponsors and Collaborators
University of East Anglia
Investigators
Principal Investigator: John M Saxton, PhD Northumbria University, Newcastle, United Kingdom
  More Information

Responsible Party: University of East Anglia
ClinicalTrials.gov Identifier: NCT02751892     History of Changes
Other Study ID Numbers: 13/EE/0060
Study First Received: April 21, 2016
Last Updated: April 21, 2016
Individual Participant Data  
Plan to Share IPD: No

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on June 23, 2017